VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $713,000 | -24.6% | 20,995 | -88.1% | 0.21% | +32.9% |
| Q1 2021 | $945,000 | -60.0% | 176,195 | +168.8% | 0.16% | -86.0% |
| Q4 2020 | $2,361,000 | -1.6% | 65,540 | +7.0% | 1.13% | +379.7% |
| Q3 2020 | $2,399,000 | -92.3% | 61,250 | -95.5% | 0.24% | -99.0% |
| Q1 2020 | $31,104,000 | +420.7% | 1,350,000 | +561.8% | 22.75% | +657.6% |
| Q4 2019 | $5,973,000 | -91.9% | 204,000 | -92.7% | 3.00% | -47.9% |
| Q3 2019 | $74,187,000 | -37.6% | 2,777,500 | -40.3% | 5.76% | -9.8% |
| Q2 2019 | $118,854,000 | +427.5% | 4,650,000 | +362.7% | 6.39% | +298.8% |
| Q1 2019 | $22,532,000 | – | 1,005,000 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |